journal
MENU ▼
Read by QxMD icon Read
search

Circulation. Cardiovascular Interventions

journal
https://www.readbyqxmd.com/read/29748221/lv-mems-a-new-challenger-against-the-champion
#1
EDITORIAL
Kiyotake Ishikawa
No abstract text is available yet for this article.
May 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29748220/remote-left-ventricular-hemodynamic-monitoring-using-a-novel-intracardiac-sensor
#2
Thomas Mondritzki, Philip Boehme, Jason White, Jin Woo Park, Jessica Hoffmann, Julia Vogel, Peter Kolkhof, Stuart Walsh, Peter Sandner, Erwin Bischoff, Wilfried Dinh, Jörg Hüser, Hubert Truebel
BACKGROUND: Heart failure (HF) remains the most common reason for hospital admission in patients aged >65 years. Despite modern drug therapy, mortality and readmission rates for patients hospitalized with HF remain high. This necessitates further research to identify early patients at risk for readmission to limit hospitalization by timely adjustment of medical therapy. Implantable devices can monitor left ventricular (LV) hemodynamics and remotely and continuously detect the early signs of decompensation to trigger interventions and reduce the risk of hospitalization for HF...
May 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29748219/frequency-reasons-and-impact-of-premature-ticagrelor-discontinuation-in-patients-undergoing-coronary-revascularization-in-routine-clinical-practice-results-from-the-bern-percutaneous-coronary-intervention-registry
#3
Thomas Zanchin, Fabrice Temperli, Alexios Karagiannis, Christian Zanchin, Markus Räsänen, Konstantinos C Koskinas, Stefan Stortecky, Lukas Hunziker, Fabien Praz, Stefan Blöchlinger, Christina Moro, Aris Moschovitis, Christian Seiler, Michael Billinger, Dik Heg, Thomas Pilgrim, Marco Valgimigli, Stephan Windecker, Lorenz Räber
BACKGROUND: Although ticagrelor has improved clinical outcomes among patients with acute coronary syndrome compared with clopidogrel, adherence to this new antiplatelet agent in real-world practice has not been fully investigated. METHODS AND RESULTS: Between November 2011 and June 2014, 1278 of 4831 consecutive patients (26.5%) undergoing percutaneous coronary intervention at a tertiary care center were treated with ticagrelor. Premature ticagrelor cessation was categorized into (1) change, when ticagrelor was replaced by prasugrel; (2) de-escalation, when ticagrelor was replaced by clopidogrel; and (3) premature discontinuation, when ticagrelor was discontinued without P2Y12 inhibitor replacement...
May 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29743161/optimizing-percutaneous-coronary-intervention-in-calcified-lesions-insights-from-optical-coherence-tomography-of-atherectomy
#4
Emile Mehanna, J Dawn Abbott, Hiram G Bezerra
No abstract text is available yet for this article.
May 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29716934/getting-to-the-right-place-at-the-right-time-another-piece-of-the-stemi-puzzle
#5
EDITORIAL
Paul N Fiorilli, Daniel M Kolansky
No abstract text is available yet for this article.
May 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29716933/taking-the-reins-on-systems-of-care-for-st-segment-elevation-myocardial-infarction-patients-a-report-from-the-american-heart-association-mission-lifeline-program
#6
Jacqueline L Green, Alice K Jacobs, DaJuanicia Holmes, Karen Chiswell, Rosalia Blanco, Eric R Bates, William French, Douglas F Kupas, Greg Mears, Matthew Roe, Brahmajee K Nallamothu
BACKGROUND: Early success with regionalization of ST-segment-elevation myocardial infarction (STEMI) care has led many states to adopt statewide prehospital STEMI hospital destination policies, allowing emergency medical services to bypass non-percutaneous coronary intervention-capable hospitals. The association between adoption of these policies and patterns of care among STEMI patients is unknown. METHODS AND RESULTS: Using data from January 1, 2013, to December 31, 2014, from the National Cardiovascular Data Registry and Acute Coronary Treatment and Intervention Outcomes Network Registry, 6 states with bypass policies (cases included Delaware, Iowa, Maryland, North Carolina, Pennsylvania, and Massachusetts) were matched to 6 states without bypass policies (controls included South Carolina, Minnesota, Virginia, Texas, New York, and Connecticut) a priori on region, hospital density, and percent state participation in the registry...
May 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29654120/interventional-cardiology-the-in-and-the-out
#7
Edward T Carreras, David O Williams
No abstract text is available yet for this article.
April 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29654119/the-oct-orion-study-a-randomized-optical-coherence-tomography-study-comparing-resolute-integrity-to-biomatrix-drug-eluting-stent-on-the-degree-of-early-stent-healing-and-late-lumen-loss
#8
Stephen W L Lee, Frankie C C Tam, Simon C C Lam, Shun-Ling Kong, Catherine P Shea, Kelvin K W Chan, Michael K L Wong, Michael P H Chan, Anthony Y T Wong, Arthur S Y Yung, Yui-Ming Lam, Lei-Wei Zhang, Karl K Y Wu, Gary S Mintz, Akiko Maehara
BACKGROUND: Durable polymers used in drug-eluting stents are considered a potential cause of hypersensitivity inflammatory response adversely affecting stent healing. Using a sequential follow-up with optical coherence tomography, we compared the differences in healing profiles of 2 drug-eluting stents with a biodegradable or durable polymer. METHODS AND RESULTS: Sixty patients with multivessel disease were prospectively enrolled to receive both study stents, which were randomly assigned to 2 individual vessels, a Resolute Integrity zotarolimus-eluting stent with a durable BioLinx polymer and a BioMatrix NeoFlex Biolimus A9-eluting stent with a biodegradable polylactic acid polymer...
April 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29643132/surgical-versus-transcatheter-aortic-valve-replacement-in-patients-with-prior-coronary-bypass-surgery-tie-goes-to-the-runner
#9
EDITORIAL
Homam Ibrahim, Frederick G P Welt
No abstract text is available yet for this article.
April 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29643131/rumpel-leede-phenomenon-after-radial-artery-catheterization
#10
Rami Khoury Abdulla, Robert D Safian
No abstract text is available yet for this article.
April 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29643130/transcatheter-versus-surgical-aortic-valve-replacement-in-patients-with-prior-coronary-artery-bypass-grafting-trends-in-utilization-and-propensity-matched-analysis-of-in-hospital-outcomes
#11
Tanush Gupta, Sahil Khera, Dhaval Kolte, Kashish Goel, Ankur Kalra, Pedro A Villablanca, Herbert D Aronow, J Dawn Abbott, Gregg C Fonarow, Cynthia C Taub, Neal S Kleiman, Giora Weisz, Ignacio Inglessis, Sammy Elmariah, Charanjit S Rihal, Mario J Garcia, Deepak L Bhatt
BACKGROUND: A significant proportion of patients requiring aortic valve replacement (AVR) have undergone prior coronary artery bypass grafting (CABG). Reoperative heart surgery is associated with increased risk. Data on relative utilization and comparative outcomes of transcatheter (TAVR) versus surgical AVR (SAVR) in patients with prior CABG are limited. METHODS AND RESULTS: We queried the 2012 to 2014 National Inpatient Sample databases to identify isolated AVR hospitalizations in adults with prior CABG...
April 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29643129/vessel-stretching-is-a-cause-of-lumen-enlargement-immediately-after-balloon-pulmonary-angioplasty-intravascular-ultrasound-analysis-in-patients-with-chronic-thromboembolic-pulmonary-hypertension
#12
Hiroto Shimokawahara, Aiko Ogawa, Hiroki Mizoguchi, Hiroki Yagi, Hidekazu Ikemiyagi, Hiromi Matsubara
BACKGROUND: Balloon pulmonary angioplasty (BPA) has become an alternative therapy for patients with chronic thromboembolic pulmonary hypertension who are ineligible for pulmonary endarterectomy. We retrospectively investigated intravascular ultrasound measurements to elucidate how the lumen enlarges immediately after BPA. METHODS AND RESULTS: A total of 326 lesions in 71 patients with chronic thromboembolic pulmonary hypertension were analyzed. The cross-sectional areas (CSAs) of the external elastic membrane and lumen measured by intravascular ultrasound before and after BPA were assessed for each lesion type (type A, ring-like stenosis lesions; type B, web lesions; type C, subtotal occlusion lesions)...
April 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29643128/effects-of-impella-on-coronary-perfusion-in-patients-with-critical-coronary-artery-stenosis
#13
Mohammad Alqarqaz, Mir Basir, Khaldoon Alaswad, William O'Neill
BACKGROUND: Mechanical circulatory support devices are used to maintain hemodynamic stability during high-risk percutaneous coronary interventions. Little is known on the effects of such devices on coronary hemodynamics in patients with significant coronary stenosis. We sought to investigate whether mechanical circulatory support in the form of Impella (Abiomed Inc, Danvers, MA) can improve coronary hemodynamics in the presence of a critical coronary stenosis. METHODS AND RESULTS: We examined coronary perfusion pressures and coronary pressure distal to a critical stenosis using a coronary pressure wire in 11 patients (12 coronary lesions) undergoing high-risk percutaneous coronary interventions with the use of mechanical circulatory support...
April 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29632239/hobson-s-choice-platelet-inhibition-and-thrombocytopenia
#14
EDITORIAL
Mamas A Mamas, Nick Curzen
No abstract text is available yet for this article.
April 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29632238/incidence-predictors-and-outcomes-of-acquired-thrombocytopenia-after-percutaneous-coronary-intervention-a-pooled-patient-level-analysis-of-the-champion-trials-cangrelor-versus-standard-therapy-to-achieve-optimal-management-of-platelet-inhibition
#15
Elliott M Groves, Deepak L Bhatt, Philippe Gabriel Steg, Efthymios N Deliargyris, Gregg W Stone, C Michael Gibson, Christian W Hamm, Kenneth W Mahaffey, Harvey D White, Dominick Angiolillo, Jayne Prats, Robert A Harrington, Matthew J Price
BACKGROUND: The influence of cangrelor on the incidence and outcomes of post-percutaneous coronary intervention (PCI) thrombocytopenia is not defined. We aimed to explore the incidence, predictors, and clinical impact of thrombocytopenia after PCI in cangrelor-treated patients. METHODS AND RESULTS: This was a pooled, patient-level analysis of the CHAMPION trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition), which compared cangrelor with clopidogrel for prevention of thrombotic complications during and after PCI...
April 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29618579/infolding-of-the-venus-p-valve-after-transcatheter-pulmonary-valve-implantation
#16
Mounir Riahi, Hak Lee Ang, Matthew Jones, Pimpak Prachasilchai, Alban-Elouan Baruteau, Worakan Promphan, Eric Rosenthal, Shakeel Ahmed Qureshi
No abstract text is available yet for this article.
April 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29540493/sex-differences-in-long-term-cause-specific-mortality-after-percutaneous-coronary-intervention-temporal-trends-and-mechanisms
#17
Claire E Raphael, Mandeep Singh, Malcolm Bell, Daniel Crusan, Ryan J Lennon, Amir Lerman, Abhiram Prasad, Charanjit S Rihal, Bernard J Gersh, Rajiv Gulati
BACKGROUND: Women have higher rates of all-cause mortality after percutaneous coronary intervention. Whether this is because of greater age and comorbidity burden or a sex-specific factor remains unclear. METHODS AND RESULTS: We retrospectively assessed cause-specific long-term mortality after index percutaneous coronary intervention over 3 time periods (1991-1997, 1998-2005, and 2006-2012). Cause of death was determined using telephone interviews, medical records, and death certificates...
March 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29540492/percutaneous-left-atrial-appendage-closure-is-a-reasonable-option-for-patients-with-atrial-fibrillation-at-high-risk-for-cerebrovascular-events
#18
Emmanuel Teiger, Jean-Benoit Thambo, Pascal Defaye, Jean-Sylvain Hermida, Sélim Abbey, Didier Klug, Jean-Michel Juliard, Jean-Luc Pasquie, Gilles Rioufol, Antoine Lepillier, Meyer Elbaz, Jerome Horvilleur, Philippe Brenot, Bertrand Pierre, Philippe Le Corvoisier
BACKGROUND: Percutaneous left atrial appendage (LAA) closure is an emerging option for patients with atrial fibrillation at high risk for cerebrovascular events. The multicenter FLAAC registry (French Nationwide Observational LAA Closure Registry) was established to assess LAA closure outcomes in everyday practice. METHODS AND RESULTS: Four hundred thirty-six patients referred from April 2013 to September 2015 to 33 French interventional cardiology centers for percutaneous LAA closure were included prospectively in the FLAAC registry...
March 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29463511/what-lies-beneath-left-atrial-appendage-occlusion-know-your-enemy
#19
EDITORIAL
Bernhard Meier
No abstract text is available yet for this article.
March 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29463510/device-thrombosis-after-percutaneous-left-atrial-appendage-occlusion-is-related-to-patient-and-procedural-characteristics-but-not-to-duration-of-postimplantation-dual-antiplatelet-therapy
#20
Radoslaw Pracon, Sripal Bangalore, Zofia Dzielinska, Marek Konka, Cezary Kepka, Mariusz Kruk, Edyta Kaczmarska-Dyrda, Joanna Petryka-Mazurkiewicz, Sebastian Bujak, Mateusz Solecki, Agnieszka Pskit, Agnieszka Dabrowska, Bartosz Sieradzki, Andrzej Plonski, Witold Ruzyllo, Adam Witkowski, Marcin Demkow
BACKGROUND: Device-related thrombus (DRT) after left atrial appendage occlusion is a worrisome finding with little knowledge about when to expect it and how to prevent it. This study sought to investigate correlates of DRT after left atrial appendage occlusion, its time of diagnosis, and particularly, association with postimplantation dual antiplatelet therapy duration. METHODS AND RESULTS: Consecutive patients (n=102) after left atrial appendage occlusion with AMPLATZER Cardiac Plug/Amulet (n=59) or WATCHMAN (n=43) were included in a prospective registry (October 2011-May 2016)...
March 2018: Circulation. Cardiovascular Interventions
journal
journal
42290
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"